[Non-obstructive coronary diseases: ANOCA, INOCA and MINOCA in focus]
Hasan Hadzalic1,2, Selma Hasific3, Christophe Wyss1
1Herzklinik Hirslanden, Zürich.
Introduction:
In addition to being the main cause of death and premature mortality in Europe, cardiovascular diseases are increasingly becoming a significant burden on public health, productivity and healthcare resources. At 34 %, coronary heart disease (CHD) represents the largest proportion of this spectrum (1). The traditional understanding of CHD, which focused almost exclusively on epicardial atherosclerotic stenoses, is now considered outdated. Although increasing attention is being paid to non-obstructive CAD, the mechanisms are largely unknown and the diagnosis may be underestimated in everyday practice. Therefore, itis crucial to recognize non-obstructive CHD in order to develop appropriate treatment strategies. The aim of this review is to provide an overview of the common definitions, causes and diagnostic steps of non-obstructive coronary artery disease.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation


